PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer

被引:102
作者
Ling, G
Ahmadian, A
Persson, Å
Undén, AB
Afink, G
Williams, C
Uhlén, M
Toftgård, R
Lundeberg, J
Pontén, F [1 ]
机构
[1] Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden
[2] Royal Inst Technol, Dept Biotechnol, S-10044 Stockholm, Sweden
[3] Karolinska Inst, Dept Dermatol, S-17176 Stockholm, Sweden
[4] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
关键词
BCC; p53; PATCHED; loss of heterozygosity; in situ hybridization; mutation;
D O I
10.1038/sj.onc.1204946
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is widely accepted that disruption of the hedgehog-patched pathway is a key event in development of basal cell cancer. In addition to patched gene alterations, p53 gene mutations are also frequent in basal cell cancer. We determined loss of heterozygosity in the patched and p53 loci as well as sequencing the p53 gene in tumors both from sporadic and hereditary cases. A total of 70 microdissected samples from tumor and adjacent skin were subjected to PCR followed by fragment analysis and DNA sequencing. We found allelic loss in the patched locus in 6/8 sporadic basal cell cancer and 17/19 hereditary tumors. All sporadic and 7/20 hereditary tumors showed p53 gene mutations. Loss of heterozygosity in the p53 locus was rare in both groups. The p53 mutations detected in hereditary tumors included rare single nucleotide deletions and unusual double-base substitutions compared to the typical ultraviolet light induced missense mutations found in sporadic tumors. Careful microdissection of individual tumors revealed genetically linked subclones with different p53 and/or patched genotype providing an insight on time sequence of genetic events. The high frequency and co-existence of genetic alterations in the patched and p53 genes suggest that both these genes are important in the development of basal cell cancer.
引用
收藏
页码:7770 / 7778
页数:9
相关论文
共 50 条
  • [21] Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines
    Murai, Y
    Hayashi, S
    Takahashi, H
    Tsuneyama, K
    Takano, Y
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (02) : 109 - 115
  • [22] Absence of germline and somatic p53 alterations in children with sporadic brain tumors
    Portwine, C
    Chilton-MacNeill, S
    Brown, C
    Sexsmith, E
    McLaughlin, J
    Malkin, D
    JOURNAL OF NEURO-ONCOLOGY, 2001, 52 (03) : 227 - 235
  • [23] Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder
    Friedrich, MG
    Riethdorf, S
    Erbersdobler, A
    Tiemer, C
    Schwaibold, H
    Sölter, JK
    Huland, E
    Riethdorf, L
    Conrad, S
    Hammerer, PG
    Huland, H
    EUROPEAN UROLOGY, 2001, 39 (02) : 159 - 166
  • [24] Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
    Chang, SC
    Lin, JK
    Lin, TC
    Liang, WY
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (01) : 65 - 75
  • [25] THE ROLE AND PROGNOSTIC-SIGNIFICANCE OF P53 GENE ALTERATIONS IN BREAST-CANCER
    ELLEDGE, RM
    FUQUA, SAW
    CLARK, GM
    PUJOL, P
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 27 (1-2) : 95 - 102
  • [26] Alterations in P53 Gene Expression in Experimental Colon Carcinoma of Wistar Rat
    Mohammadzadeh, Peyman
    Noroozi Gorgani, Bahman
    Ghiasi, Sanaz
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2024, 39 (02): : 135 - 143
  • [27] B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas
    Stamatelli, Angeliki
    Saetta, Angelica A.
    Bei, Thaleia
    Kavantzas, Nicolaos
    Michalopoulos, Nicolaos V.
    Patsouris, Efstratios
    Aroni, Kiriaki
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 633 - 637
  • [28] The role of p53 isoforms' expression and p53 mutation status in renal cell cancer prognosis
    Florijan, Marijana Knezovic
    Ozretic, Petar
    Bujak, Maro
    Pezze, Laura
    Ciribilli, Yari
    Kastelan, Zeljko
    Slade, Neda
    Hudolin, Tvrtko
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 578.e1 - 578.e10
  • [29] Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status
    Xu, Ye
    Yao, Lihua
    Zhao, Ailian
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Lu, Youyong
    Xie, Yuntao
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) : 2761 - 2766
  • [30] p53: The barrier to cancer stem cell formation
    Aloni-Grinstein, Ronit
    Shetzer, Yoav
    Kaufman, Tom
    Rotter, Varda
    FEBS LETTERS, 2014, 588 (16) : 2580 - 2589